2,3,5,4'-	B:C0964606
Tetrahydroxystilbene-2-O-β-D-Glucoside	I:C0964606
Attenuates	O
Ischemia	O
/	O
Reperfusion	O
-	I:C0035126
Induced	I:C0035126
Brain	O
Injury	I:C0270611
in	O
Rats	O
by	O
Promoting	O
Angiogenesis	O
cerebral	O
ischemia	I:C0917798
can	O
cause	O
brain	O
infarcts	I:C0521542
,	O
which	O
are	O
difficult	O
to	O
recover	O
due	O
to	O
poor	O
angiogenesis	I:C0302600
.	O

2,3,5,4'-	O
Tetrahydroxystilbene-2-O-β-D-Glucoside	I:C0964606
Attenuates	O
Ischemia	B:C0022116
/	O
Reperfusion	O
-	I:C0035126
Induced	I:C0035126
Brain	O
Injury	I:C0270611
in	O
Rats	O
by	O
Promoting	O
Angiogenesis	O
cerebral	O
ischemia	I:C0917798
can	O
cause	O
brain	O
infarcts	I:C0521542
,	O
which	O
are	O
difficult	O
to	O
recover	O
due	O
to	O
poor	O
angiogenesis	I:C0302600
.	O

2,3,5,4'-	O
Tetrahydroxystilbene-2-O-β-D-Glucoside	I:C0964606
Attenuates	O
Ischemia	O
/	O
Reperfusion	B:C0035126
-	I:C0035126
Induced	I:C0035126
Brain	O
Injury	I:C0270611
in	O
Rats	O
by	O
Promoting	O
Angiogenesis	O
cerebral	O
ischemia	I:C0917798
can	O
cause	O
brain	O
infarcts	I:C0521542
,	O
which	O
are	O
difficult	O
to	O
recover	O
due	O
to	O
poor	O
angiogenesis	I:C0302600
.	O

2,3,5,4'-	O
Tetrahydroxystilbene-2-O-β-D-Glucoside	I:C0964606
Attenuates	O
Ischemia	O
/	O
Reperfusion	O
-	I:C0035126
Induced	I:C0035126
Brain	B:C0270611
Injury	I:C0270611
in	O
Rats	O
by	O
Promoting	O
Angiogenesis	O
cerebral	O
ischemia	I:C0917798
can	O
cause	O
brain	O
infarcts	I:C0521542
,	O
which	O
are	O
difficult	O
to	O
recover	O
due	O
to	O
poor	O
angiogenesis	I:C0302600
.	O

2,3,5,4'-	O
Tetrahydroxystilbene-2-O-β-D-Glucoside	I:C0964606
Attenuates	O
Ischemia	O
/	O
Reperfusion	O
-	I:C0035126
Induced	I:C0035126
Brain	O
Injury	I:C0270611
in	O
Rats	B:C0034721
by	O
Promoting	O
Angiogenesis	O
cerebral	O
ischemia	I:C0917798
can	O
cause	O
brain	O
infarcts	I:C0521542
,	O
which	O
are	O
difficult	O
to	O
recover	O
due	O
to	O
poor	O
angiogenesis	I:C0302600
.	O

2,3,5,4'-	O
Tetrahydroxystilbene-2-O-β-D-Glucoside	I:C0964606
Attenuates	O
Ischemia	O
/	O
Reperfusion	O
-	I:C0035126
Induced	I:C0035126
Brain	O
Injury	I:C0270611
in	O
Rats	O
by	O
Promoting	O
Angiogenesis	B:C0302600
cerebral	O
ischemia	I:C0917798
can	O
cause	O
brain	O
infarcts	I:C0521542
,	O
which	O
are	O
difficult	O
to	O
recover	O
due	O
to	O
poor	O
angiogenesis	I:C0302600
.	O

2,3,5,4'-	O
Tetrahydroxystilbene-2-O-β-D-Glucoside	I:C0964606
Attenuates	O
Ischemia	O
/	O
Reperfusion	O
-	I:C0035126
Induced	I:C0035126
Brain	O
Injury	I:C0270611
in	O
Rats	O
by	O
Promoting	O
Angiogenesis	O
cerebral	B:C0917798
ischemia	I:C0917798
can	O
cause	O
brain	O
infarcts	I:C0521542
,	O
which	O
are	O
difficult	O
to	O
recover	O
due	O
to	O
poor	O
angiogenesis	I:C0302600
.	O

2,3,5,4'-	O
Tetrahydroxystilbene-2-O-β-D-Glucoside	I:C0964606
Attenuates	O
Ischemia	O
/	O
Reperfusion	O
-	I:C0035126
Induced	I:C0035126
Brain	O
Injury	I:C0270611
in	O
Rats	O
by	O
Promoting	O
Angiogenesis	O
cerebral	O
ischemia	I:C0917798
can	O
cause	O
brain	B:C0521542
infarcts	I:C0521542
,	O
which	O
are	O
difficult	O
to	O
recover	O
due	O
to	O
poor	O
angiogenesis	I:C0302600
.	O

2,3,5,4'-	O
Tetrahydroxystilbene-2-O-β-D-Glucoside	I:C0964606
Attenuates	O
Ischemia	O
/	O
Reperfusion	O
-	I:C0035126
Induced	I:C0035126
Brain	O
Injury	I:C0270611
in	O
Rats	O
by	O
Promoting	O
Angiogenesis	O
cerebral	O
ischemia	I:C0917798
can	O
cause	O
brain	O
infarcts	I:C0521542
,	O
which	O
are	O
difficult	O
to	O
recover	O
due	O
to	O
poor	B:C0302600
angiogenesis	I:C0302600
.	O

2,3,5,4'-	B:C0964606
Tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
is	O
a	O
natural	O
polyphenol	I:C0071649
,	O
has	O
antioxidant	O
and	O
anti-inflammatory	O
activity	O
,	O
and	O
can	O
protect	O
from	O
ischemic	O
neuronal	O
injury	I:C0161479
.	O

2,3,5,4'-	O
Tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
is	O
a	O
natural	B:C0071649
polyphenol	I:C0071649
,	O
has	O
antioxidant	O
and	O
anti-inflammatory	O
activity	O
,	O
and	O
can	O
protect	O
from	O
ischemic	O
neuronal	O
injury	I:C0161479
.	O

2,3,5,4'-	O
Tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
is	O
a	O
natural	O
polyphenol	I:C0071649
,	O
has	O
antioxidant	B:C1148564
and	O
anti-inflammatory	O
activity	O
,	O
and	O
can	O
protect	O
from	O
ischemic	O
neuronal	O
injury	I:C0161479
.	O

2,3,5,4'-	O
Tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
is	O
a	O
natural	O
polyphenol	I:C0071649
,	O
has	O
antioxidant	O
and	O
anti-inflammatory	B:C0003209
activity	O
,	O
and	O
can	O
protect	O
from	O
ischemic	O
neuronal	O
injury	I:C0161479
.	O

2,3,5,4'-	O
Tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
is	O
a	O
natural	O
polyphenol	I:C0071649
,	O
has	O
antioxidant	O
and	O
anti-inflammatory	O
activity	O
,	O
and	O
can	O
protect	O
from	O
ischemic	B:C0022116
neuronal	O
injury	I:C0161479
.	O

2,3,5,4'-	O
Tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
is	O
a	O
natural	O
polyphenol	I:C0071649
,	O
has	O
antioxidant	O
and	O
anti-inflammatory	O
activity	O
,	O
and	O
can	O
protect	O
from	O
ischemic	O
neuronal	B:C0161479
injury	I:C0161479
.	O

However	O
,	O
little	O
is	O
known	O
about	O
the	O
effect	O
of	O
2,3,5,4'-	B:C0964606
tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
on	O
brain	O
microcirculation	O
after	O
stroke	O
.	O

However	O
,	O
little	O
is	O
known	O
about	O
the	O
effect	O
of	O
2,3,5,4'-	O
tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
on	O
brain	B:C0006104
microcirculation	O
after	O
stroke	O
.	O

However	O
,	O
little	O
is	O
known	O
about	O
the	O
effect	O
of	O
2,3,5,4'-	O
tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
on	O
brain	O
microcirculation	B:C0025962
after	O
stroke	O
.	O

However	O
,	O
little	O
is	O
known	O
about	O
the	O
effect	O
of	O
2,3,5,4'-	O
tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
on	O
brain	O
microcirculation	O
after	O
stroke	B:C0038454
.	O

This	O
study	B:C2603343
aimed	O
at	O
investigating	O
the	O
influence	O
of	O
2,3,5,4'-	O
tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
on	O
brain	O
lesions	I:C0221505
and	O
angiogenesis	O
after	O
stroke	O
.	O

This	O
study	O
aimed	O
at	O
investigating	O
the	O
influence	O
of	O
2,3,5,4'-	B:C0964606
tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
on	O
brain	O
lesions	I:C0221505
and	O
angiogenesis	O
after	O
stroke	O
.	O

This	O
study	O
aimed	O
at	O
investigating	O
the	O
influence	O
of	O
2,3,5,4'-	O
tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
on	O
brain	B:C0221505
lesions	I:C0221505
and	O
angiogenesis	O
after	O
stroke	O
.	O

This	O
study	O
aimed	O
at	O
investigating	O
the	O
influence	O
of	O
2,3,5,4'-	O
tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
on	O
brain	O
lesions	I:C0221505
and	O
angiogenesis	B:C0302600
after	O
stroke	O
.	O

This	O
study	O
aimed	O
at	O
investigating	O
the	O
influence	O
of	O
2,3,5,4'-	O
tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
on	O
brain	O
lesions	I:C0221505
and	O
angiogenesis	O
after	O
stroke	B:C0038454
.	O

Sprague	B:C0034715
-	I:C0034715
Dawley	I:C0034715
rats	I:C0034715
were	O
subjected	O
to	O
right	O
middle	I:C0740391
cerebral	I:C0740391
artery	I:C0740391
occlusion	I:C0740391
and	O
treated	O
with	I:C0332293
vehicle	O
,	O
nimodipine	O
,	O
or	O
different	O
doses	O
of	O
2,3,5,4'-	O
tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
daily	O
beginning	O
at	O
6	O
h	O
post	O
-	I:C0740391
middle	I:C0740391
cerebral	I:C0740391
artery	I:C0740391
occlusion	I:C0740391
for	O
14	O
days	O
.	O

Sprague	O
-	I:C0034715
Dawley	I:C0034715
rats	I:C0034715
were	O
subjected	O
to	O
right	B:C0740391
middle	I:C0740391
cerebral	I:C0740391
artery	I:C0740391
occlusion	I:C0740391
and	O
treated	O
with	I:C0332293
vehicle	O
,	O
nimodipine	O
,	O
or	O
different	O
doses	O
of	O
2,3,5,4'-	O
tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
daily	O
beginning	O
at	O
6	O
h	O
post	O
-	I:C0740391
middle	I:C0740391
cerebral	I:C0740391
artery	I:C0740391
occlusion	I:C0740391
for	O
14	O
days	O
.	O

Sprague	O
-	I:C0034715
Dawley	I:C0034715
rats	I:C0034715
were	O
subjected	O
to	O
right	O
middle	I:C0740391
cerebral	I:C0740391
artery	I:C0740391
occlusion	I:C0740391
and	O
treated	B:C0332293
with	I:C0332293
vehicle	O
,	O
nimodipine	O
,	O
or	O
different	O
doses	O
of	O
2,3,5,4'-	O
tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
daily	O
beginning	O
at	O
6	O
h	O
post	O
-	I:C0740391
middle	I:C0740391
cerebral	I:C0740391
artery	I:C0740391
occlusion	I:C0740391
for	O
14	O
days	O
.	O

Sprague	O
-	I:C0034715
Dawley	I:C0034715
rats	I:C0034715
were	O
subjected	O
to	O
right	O
middle	I:C0740391
cerebral	I:C0740391
artery	I:C0740391
occlusion	I:C0740391
and	O
treated	O
with	I:C0332293
vehicle	O
,	O
nimodipine	B:C0028094
,	O
or	O
different	O
doses	O
of	O
2,3,5,4'-	O
tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
daily	O
beginning	O
at	O
6	O
h	O
post	O
-	I:C0740391
middle	I:C0740391
cerebral	I:C0740391
artery	I:C0740391
occlusion	I:C0740391
for	O
14	O
days	O
.	O

Sprague	O
-	I:C0034715
Dawley	I:C0034715
rats	I:C0034715
were	O
subjected	O
to	O
right	O
middle	I:C0740391
cerebral	I:C0740391
artery	I:C0740391
occlusion	I:C0740391
and	O
treated	O
with	I:C0332293
vehicle	O
,	O
nimodipine	O
,	O
or	O
different	O
doses	O
of	O
2,3,5,4'-	B:C0964606
tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
daily	O
beginning	O
at	O
6	O
h	O
post	O
-	I:C0740391
middle	I:C0740391
cerebral	I:C0740391
artery	I:C0740391
occlusion	I:C0740391
for	O
14	O
days	O
.	O

Sprague	O
-	I:C0034715
Dawley	I:C0034715
rats	I:C0034715
were	O
subjected	O
to	O
right	O
middle	I:C0740391
cerebral	I:C0740391
artery	I:C0740391
occlusion	I:C0740391
and	O
treated	O
with	I:C0332293
vehicle	O
,	O
nimodipine	O
,	O
or	O
different	O
doses	O
of	O
2,3,5,4'-	O
tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
daily	O
beginning	O
at	O
6	O
h	O
post	B:C0740391
-	I:C0740391
middle	I:C0740391
cerebral	I:C0740391
artery	I:C0740391
occlusion	I:C0740391
for	O
14	O
days	O
.	O

The	O
volume	O
of	O
cerebral	B:C0007785
infarcts	I:C0007785
,	O
degree	O
of	O
neurological	O
dysfunction	I:C1709219
,	O
and	O
level	O
of	O
microvessel	O
density	O
were	O
determined	O
longitudinally	O
.	O

The	O
volume	O
of	O
cerebral	O
infarcts	I:C0007785
,	O
degree	O
of	O
neurological	B:C1709219
dysfunction	I:C1709219
,	O
and	O
level	O
of	O
microvessel	O
density	O
were	O
determined	O
longitudinally	O
.	O

The	O
volume	O
of	O
cerebral	O
infarcts	I:C0007785
,	O
degree	O
of	O
neurological	O
dysfunction	I:C1709219
,	O
and	O
level	O
of	O
microvessel	B:C2350570
density	O
were	O
determined	O
longitudinally	O
.	O

The	O
levels	O
of	O
vascular	B:C1256770
endothelial	I:C1256770
growth	I:C1256770
factor	I:C1256770
,	O
angiopoietin	O
1	I:C3853567
,	I:C3853567
and	I:C3853567
angiopoietin	I:C3853567
receptor	I:C3853567
-	I:C3853567
2	I:C3853567
expression	O
in	O
the	O
brain	O
lesions	I:C0221505
were	O
characterized	O
by	O
immunohistochemistry	O
and	O
Western	O
blot	I:C0949466
assays	I:C0949466
at	O
14	O
days	O
post	O
-	I:C0740391
middle	I:C0740391
cerebral	I:C0740391
artery	I:C0740391
occlusion	I:C0740391
.	O

The	O
levels	O
of	O
vascular	O
endothelial	I:C1256770
growth	I:C1256770
factor	I:C1256770
,	O
angiopoietin	B:C3853567
1	I:C3853567
,	I:C3853567
and	I:C3853567
angiopoietin	I:C3853567
receptor	I:C3853567
-	I:C3853567
2	I:C3853567
expression	O
in	O
the	O
brain	O
lesions	I:C0221505
were	O
characterized	O
by	O
immunohistochemistry	O
and	O
Western	O
blot	I:C0949466
assays	I:C0949466
at	O
14	O
days	O
post	O
-	I:C0740391
middle	I:C0740391
cerebral	I:C0740391
artery	I:C0740391
occlusion	I:C0740391
.	O

The	O
levels	O
of	O
vascular	O
endothelial	I:C1256770
growth	I:C1256770
factor	I:C1256770
,	O
angiopoietin	O
1	I:C3853567
,	I:C3853567
and	I:C3853567
angiopoietin	I:C3853567
receptor	I:C3853567
-	I:C3853567
2	I:C3853567
expression	O
in	O
the	O
brain	B:C0221505
lesions	I:C0221505
were	O
characterized	O
by	O
immunohistochemistry	O
and	O
Western	O
blot	I:C0949466
assays	I:C0949466
at	O
14	O
days	O
post	O
-	I:C0740391
middle	I:C0740391
cerebral	I:C0740391
artery	I:C0740391
occlusion	I:C0740391
.	O

The	O
levels	O
of	O
vascular	O
endothelial	I:C1256770
growth	I:C1256770
factor	I:C1256770
,	O
angiopoietin	O
1	I:C3853567
,	I:C3853567
and	I:C3853567
angiopoietin	I:C3853567
receptor	I:C3853567
-	I:C3853567
2	I:C3853567
expression	O
in	O
the	O
brain	O
lesions	I:C0221505
were	O
characterized	O
by	O
immunohistochemistry	B:C0021044
and	O
Western	O
blot	I:C0949466
assays	I:C0949466
at	O
14	O
days	O
post	O
-	I:C0740391
middle	I:C0740391
cerebral	I:C0740391
artery	I:C0740391
occlusion	I:C0740391
.	O

The	O
levels	O
of	O
vascular	O
endothelial	I:C1256770
growth	I:C1256770
factor	I:C1256770
,	O
angiopoietin	O
1	I:C3853567
,	I:C3853567
and	I:C3853567
angiopoietin	I:C3853567
receptor	I:C3853567
-	I:C3853567
2	I:C3853567
expression	O
in	O
the	O
brain	O
lesions	I:C0221505
were	O
characterized	O
by	O
immunohistochemistry	O
and	O
Western	B:C0949466
blot	I:C0949466
assays	I:C0949466
at	O
14	O
days	O
post	O
-	I:C0740391
middle	I:C0740391
cerebral	I:C0740391
artery	I:C0740391
occlusion	I:C0740391
.	O

The	O
levels	O
of	O
vascular	O
endothelial	I:C1256770
growth	I:C1256770
factor	I:C1256770
,	O
angiopoietin	O
1	I:C3853567
,	I:C3853567
and	I:C3853567
angiopoietin	I:C3853567
receptor	I:C3853567
-	I:C3853567
2	I:C3853567
expression	O
in	O
the	O
brain	O
lesions	I:C0221505
were	O
characterized	O
by	O
immunohistochemistry	O
and	O
Western	O
blot	I:C0949466
assays	I:C0949466
at	O
14	O
days	O
post	B:C0740391
-	I:C0740391
middle	I:C0740391
cerebral	I:C0740391
artery	I:C0740391
occlusion	I:C0740391
.	O

We	O
found	O
that	O
2,3,5,4'-	B:C0964606
tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
significantly	O
promoted	O
postoperative	O
recovery	I:C4304804
in	O
rats	O
by	O
minimizing	O
the	O
volume	O
of	O
cerebral	O
infarcts	I:C0007785
and	O
improving	O
neurological	O
dysfunction	I:C1709219
in	O
a	O
dose	O
-	O
and	O
time	O
-	O
dependent	O
manner	O
.	O

We	O
found	O
that	O
2,3,5,4'-	O
tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
significantly	O
promoted	O
postoperative	B:C4304804
recovery	I:C4304804
in	O
rats	O
by	O
minimizing	O
the	O
volume	O
of	O
cerebral	O
infarcts	I:C0007785
and	O
improving	O
neurological	O
dysfunction	I:C1709219
in	O
a	O
dose	O
-	O
and	O
time	O
-	O
dependent	O
manner	O
.	O

We	O
found	O
that	O
2,3,5,4'-	O
tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
significantly	O
promoted	O
postoperative	O
recovery	I:C4304804
in	O
rats	B:C0034721
by	O
minimizing	O
the	O
volume	O
of	O
cerebral	O
infarcts	I:C0007785
and	O
improving	O
neurological	O
dysfunction	I:C1709219
in	O
a	O
dose	O
-	O
and	O
time	O
-	O
dependent	O
manner	O
.	O

We	O
found	O
that	O
2,3,5,4'-	O
tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
significantly	O
promoted	O
postoperative	O
recovery	I:C4304804
in	O
rats	O
by	O
minimizing	O
the	O
volume	O
of	O
cerebral	B:C0007785
infarcts	I:C0007785
and	O
improving	O
neurological	O
dysfunction	I:C1709219
in	O
a	O
dose	O
-	O
and	O
time	O
-	O
dependent	O
manner	O
.	O

We	O
found	O
that	O
2,3,5,4'-	O
tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
significantly	O
promoted	O
postoperative	O
recovery	I:C4304804
in	O
rats	O
by	O
minimizing	O
the	O
volume	O
of	O
cerebral	O
infarcts	I:C0007785
and	O
improving	O
neurological	B:C1709219
dysfunction	I:C1709219
in	O
a	O
dose	O
-	O
and	O
time	O
-	O
dependent	O
manner	O
.	O

Additionally	O
,	O
2,3,5,4'-	B:C0964606
tetrahydroxystilbene-2-O-β-D-glucoside	I:C0964606
significantly	O
increased	O
the	O
microvessel	O
density	O
in	O
the	O
brain	O
and	O
upregulated	O
CD31	O
expression	O
in	O
ischemic	O
penumbra	O
,	O
relative	O
to	O
that	O
in	O
the	O
control	O
.	O

Additionally	O
,	O
2,3,5,4'-	O
tetrahydroxystilbene-2-O-β-D-glucoside	I:C0964606
significantly	O
increased	O
the	O
microvessel	B:C2350570
density	O
in	O
the	O
brain	O
and	O
upregulated	O
CD31	O
expression	O
in	O
ischemic	O
penumbra	O
,	O
relative	O
to	O
that	O
in	O
the	O
control	O
.	O

Additionally	O
,	O
2,3,5,4'-	O
tetrahydroxystilbene-2-O-β-D-glucoside	I:C0964606
significantly	O
increased	O
the	O
microvessel	O
density	O
in	O
the	O
brain	B:C0006104
and	O
upregulated	O
CD31	O
expression	O
in	O
ischemic	O
penumbra	O
,	O
relative	O
to	O
that	O
in	O
the	O
control	O
.	O

Additionally	O
,	O
2,3,5,4'-	O
tetrahydroxystilbene-2-O-β-D-glucoside	I:C0964606
significantly	O
increased	O
the	O
microvessel	O
density	O
in	O
the	O
brain	O
and	O
upregulated	B:C0041904
CD31	O
expression	O
in	O
ischemic	O
penumbra	O
,	O
relative	O
to	O
that	O
in	O
the	O
control	O
.	O

Additionally	O
,	O
2,3,5,4'-	O
tetrahydroxystilbene-2-O-β-D-glucoside	I:C0964606
significantly	O
increased	O
the	O
microvessel	O
density	O
in	O
the	O
brain	O
and	O
upregulated	O
CD31	B:C0081939
expression	O
in	O
ischemic	O
penumbra	O
,	O
relative	O
to	O
that	O
in	O
the	O
control	O
.	O

Additionally	O
,	O
2,3,5,4'-	O
tetrahydroxystilbene-2-O-β-D-glucoside	I:C0964606
significantly	O
increased	O
the	O
microvessel	O
density	O
in	O
the	O
brain	O
and	O
upregulated	O
CD31	O
expression	B:C1171362
in	O
ischemic	O
penumbra	O
,	O
relative	O
to	O
that	O
in	O
the	O
control	O
.	O

Additionally	O
,	O
2,3,5,4'-	O
tetrahydroxystilbene-2-O-β-D-glucoside	I:C0964606
significantly	O
increased	O
the	O
microvessel	O
density	O
in	O
the	O
brain	O
and	O
upregulated	O
CD31	O
expression	O
in	O
ischemic	B:C0022116
penumbra	O
,	O
relative	O
to	O
that	O
in	O
the	O
control	O
.	O

Finally	O
,	O
treatment	B:C0332293
with	I:C0332293
2,3,5,4'-	O
tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
significantly	O
upregulated	O
the	O
relative	O
levels	O
of	O
vascular	O
endothelial	I:C1256770
growth	I:C1256770
factor	I:C1256770
,	O
angiopoietin	O
1	I:C3853567
,	I:C3853567
and	I:C3853567
angiopoietin	I:C3853567
receptor	I:C3853567
-	I:C3853567
2	I:C3853567
expression	O
in	O
the	O
brain	O
lesions	I:C0221505
of	O
rats	O
.	O

Finally	O
,	O
treatment	O
with	I:C0332293
2,3,5,4'-	B:C0964606
tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
significantly	O
upregulated	O
the	O
relative	O
levels	O
of	O
vascular	O
endothelial	I:C1256770
growth	I:C1256770
factor	I:C1256770
,	O
angiopoietin	O
1	I:C3853567
,	I:C3853567
and	I:C3853567
angiopoietin	I:C3853567
receptor	I:C3853567
-	I:C3853567
2	I:C3853567
expression	O
in	O
the	O
brain	O
lesions	I:C0221505
of	O
rats	O
.	O

Finally	O
,	O
treatment	O
with	I:C0332293
2,3,5,4'-	O
tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
significantly	O
upregulated	B:C0041904
the	O
relative	O
levels	O
of	O
vascular	O
endothelial	I:C1256770
growth	I:C1256770
factor	I:C1256770
,	O
angiopoietin	O
1	I:C3853567
,	I:C3853567
and	I:C3853567
angiopoietin	I:C3853567
receptor	I:C3853567
-	I:C3853567
2	I:C3853567
expression	O
in	O
the	O
brain	O
lesions	I:C0221505
of	O
rats	O
.	O

Finally	O
,	O
treatment	O
with	I:C0332293
2,3,5,4'-	O
tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
significantly	O
upregulated	O
the	O
relative	O
levels	O
of	O
vascular	B:C1256770
endothelial	I:C1256770
growth	I:C1256770
factor	I:C1256770
,	O
angiopoietin	O
1	I:C3853567
,	I:C3853567
and	I:C3853567
angiopoietin	I:C3853567
receptor	I:C3853567
-	I:C3853567
2	I:C3853567
expression	O
in	O
the	O
brain	O
lesions	I:C0221505
of	O
rats	O
.	O

Finally	O
,	O
treatment	O
with	I:C0332293
2,3,5,4'-	O
tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
significantly	O
upregulated	O
the	O
relative	O
levels	O
of	O
vascular	O
endothelial	I:C1256770
growth	I:C1256770
factor	I:C1256770
,	O
angiopoietin	B:C3853567
1	I:C3853567
,	I:C3853567
and	I:C3853567
angiopoietin	I:C3853567
receptor	I:C3853567
-	I:C3853567
2	I:C3853567
expression	O
in	O
the	O
brain	O
lesions	I:C0221505
of	O
rats	O
.	O

Finally	O
,	O
treatment	O
with	I:C0332293
2,3,5,4'-	O
tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
significantly	O
upregulated	O
the	O
relative	O
levels	O
of	O
vascular	O
endothelial	I:C1256770
growth	I:C1256770
factor	I:C1256770
,	O
angiopoietin	O
1	I:C3853567
,	I:C3853567
and	I:C3853567
angiopoietin	I:C3853567
receptor	I:C3853567
-	I:C3853567
2	I:C3853567
expression	O
in	O
the	O
brain	B:C0221505
lesions	I:C0221505
of	O
rats	O
.	O

Finally	O
,	O
treatment	O
with	I:C0332293
2,3,5,4'-	O
tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
significantly	O
upregulated	O
the	O
relative	O
levels	O
of	O
vascular	O
endothelial	I:C1256770
growth	I:C1256770
factor	I:C1256770
,	O
angiopoietin	O
1	I:C3853567
,	I:C3853567
and	I:C3853567
angiopoietin	I:C3853567
receptor	I:C3853567
-	I:C3853567
2	I:C3853567
expression	O
in	O
the	O
brain	O
lesions	I:C0221505
of	O
rats	B:C0034721
.	O

Therefore	O
,	O
these	O
data	O
indicated	B:C1444656
that	O
2,3,5,4'-	O
tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
treatment	O
promoted	O
angiogenesis	O
and	O
recovery	O
from	O
ischemia	O
/	I:C0035126
reperfusion	I:C0035126
-	O
induced	O
brain	O
injury	I:C0270611
in	O
rats	O
.	O

Therefore	O
,	O
these	O
data	O
indicated	O
that	O
2,3,5,4'-	B:C0964606
tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
treatment	O
promoted	O
angiogenesis	O
and	O
recovery	O
from	O
ischemia	O
/	I:C0035126
reperfusion	I:C0035126
-	O
induced	O
brain	O
injury	I:C0270611
in	O
rats	O
.	O

Therefore	O
,	O
these	O
data	O
indicated	O
that	O
2,3,5,4'-	O
tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
treatment	B:C0332293
promoted	O
angiogenesis	O
and	O
recovery	O
from	O
ischemia	O
/	I:C0035126
reperfusion	I:C0035126
-	O
induced	O
brain	O
injury	I:C0270611
in	O
rats	O
.	O

Therefore	O
,	O
these	O
data	O
indicated	O
that	O
2,3,5,4'-	O
tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
treatment	O
promoted	O
angiogenesis	B:C0302600
and	O
recovery	O
from	O
ischemia	O
/	I:C0035126
reperfusion	I:C0035126
-	O
induced	O
brain	O
injury	I:C0270611
in	O
rats	O
.	O

Therefore	O
,	O
these	O
data	O
indicated	O
that	O
2,3,5,4'-	O
tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
treatment	O
promoted	O
angiogenesis	O
and	O
recovery	O
from	O
ischemia	B:C0035126
/	I:C0035126
reperfusion	I:C0035126
-	O
induced	O
brain	O
injury	I:C0270611
in	O
rats	O
.	O

Therefore	O
,	O
these	O
data	O
indicated	O
that	O
2,3,5,4'-	O
tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
treatment	O
promoted	O
angiogenesis	O
and	O
recovery	O
from	O
ischemia	O
/	I:C0035126
reperfusion	I:C0035126
-	O
induced	O
brain	B:C0270611
injury	I:C0270611
in	O
rats	O
.	O

Therefore	O
,	O
these	O
data	O
indicated	O
that	O
2,3,5,4'-	O
tetrahydroxystilbene	I:C0964606
-2-O-β-D-glucoside	I:C0964606
treatment	O
promoted	O
angiogenesis	O
and	O
recovery	O
from	O
ischemia	O
/	I:C0035126
reperfusion	I:C0035126
-	O
induced	O
brain	O
injury	I:C0270611
in	O
rats	B:C0034721
.	O

